Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The prostate‐specific phosphatase and tensin homolog deleted on chromosome 10 (<i>Pten)</i> gene‐conditional knockout (KO) mouse carcinogenesis model is highly desirable for studies of prostate cancer biology and chemoprevention due to its close resemblance of primary molecular defect and many histopathological features of human prostate cancer including androgen response and disease progression from prostatic intraepithelial neoplasia to invasive adenocarcinoma. Here, we profiled the proteome and transcriptome of the <i>Pten</i>‐KO mouse prostate tumors for global macromolecular expression alterations for signaling changes and biomarker signatures. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>For proteomics, four pairs of whole prostates from tissue‐specific conditional knockout <i>Pten</i>‐KO mice (12‐15 weeks of age) and their respective wild‐type littermates housed in the same cages were analyzed by 8‐plex isobaric tags for relative and absolute quantitation iTRAQ. For microarray transcriptomic analysis, three additional matched pairs of prostate/tumor specimens from respective mice at 20 to 22 weeks of age were used. Real‐time quantitative reverse transcription‐polymerase chain reaction was used to verify the trends of protein and RNA expression changes. Gene Set Enrichment Analysis and Ingenuity Pathway Analysis were carried out for bioinformatic characterizations of pathways and networks. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>At the macromolecular level, proteomic and transcriptomic analyses complement and cross‐validate to reveal overexpression signatures including inflammation and immune alterations, in particular, neutrophil/myeloid lineage suppressor cell features, chromatin/histones, ion and nutrient transporters, and select glutathione peroxidases and transferases in <i>Pten</i>‐KO prostate tumors. Suppressed expression patterns in the <i>Pten</i>‐KO prostate tumors included glandular differentiation such as secretory proteins and androgen receptor targets, smooth muscle features, and endoplasmic reticulum stress proteins. Bioinformatic analyses identified <i>immune and inflammation responses</i> as the most profound macromolecular landscape changes, and the predicted key nodal activities through Akt, nuclear factor‐kappaB, and P53 in the <i>Pten</i>‐KO prostate tumor. Comparison with other genetically modified mouse prostate carcinogenesis models revealed notable molecular distinctions, especially the dominance of <i>immune and inflammation features</i> in the <i>Pten</i>‐KO prostate tumors. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our work identified prominent macromolecular signatures and key nodal molecules that help to illuminate the patho‐ and immunobiology of <i>Pten</i>‐loss driven prostate cancer and can facilitate the choice of biomarkers for chemoprevention and interception studies in this clinically relevant mouse prostate cancer model. </p></section>

Jnk and Pten Cooperatively Control the Development of Invasive Adenocarcinoma of the Prostate

Nkx3.1 and P27kip1cooperate in Proliferation Inhibition and Apoptosis Induction in Human Androgen–Independent Prostate Cancer Cells

Data from <i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN.

JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses.

Signal integration by JNK and p38 MAPK pathways in cancer development

A Subset of Metastatic Pancreatic Ductal Adenocarcinomas Depends Quantitatively on Oncogenic Kras/Mek/Erk-Induced Hyperactive Mtor Signalling

C-Jun N-terminal Kinase 2 Suppresses Pancreatic Cancer Growth and Invasion and is Opposed by C-Jun N-terminal Kinase 1.

Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis

Data from Murine Cell Lines Derived from <i>Pten</i> Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development

Abstract B45: Combinatorial Activation of PI3-kinase and Ras-Raf Signaling in Mouse Models of Advanced Prostate Cancer

Either Kras Activation or Pten Loss Similarly Enhance the Dominant-Stable CTNNB1-induced Genetic Program to Promote Granulosa Cell Tumor Development in the Ovary and Testis

Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer

Essential Role of AKT-1/Protein Kinase Bα in PTEN-Controlled Tumorigenesis

Pten Deficiency Activates Distinct Downstream Signaling Pathways in A Tissue-Specific Manner

JNK is Required for Maintaining the Tumor-Initiating Cell-Like Properties of Acquired Chemoresistant Human Cancer Cells.

Conditional Deletion of the Pten Gene in the Mouse Prostate Induces Prostatic Intraepithelial Neoplasms at Early Ages but a Slow Progression to Prostate Tumors.

Either Kras Activation or Pten Loss Similarly Enhance the Mutant CTNNB1-Induced Genetic Program to Promote Granulosa Cell Tumor Development in Ovary and Testis.

The JNK and Hippo pathways control epithelial integrity and prevent tumor initiation by regulating an overlapping transcriptome

Murine Cell Lines Derived From Pten Null Prostate Cancer Show The Critical Role Of Pten In Hormone Refractory Prostate Cancer Development

NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.